GW29-e2015 Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease

To date there have been no randomized clinical trials comparing the outcomes of two bioabsorbable polymer coated coronary stents. Micell Technologies has developed the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (“MiStent”) consisting of a cobalt-chromium stent platform